Skip to content

Abstract 16527: Inflammatory Markers in Homozygous Familial Hypercholesterolaemia Are Not Related to LDL-Cholesterol or ASCVD

Nov 2026 · Circulation · 0 citations

Abstract

Introduction Homozygous familial hypercholesterolaemia (HoFH) is a rare autosomal semi-dominant disorder characterised by extremely elevated LDL-C from birth, extensive premature atherosclerosis and, if untreated, early death from atherosclerotic cardiovascular disease (ASCVD). In addition to the traditional cardiovascular risk factors, inflammation is an important risk factor for ASCVD with high sensitivity C-reactive protein (hsCRP) and interleukin-6 (IL-6) being used to identify those at greatest risk. hsCRP has been shown to be more predictive of future cardiovascular events compared to LDL-C when measured in the general population but are inflammatory markers a true marker of ASCVD? Research Questions Does systemic inflammation parallel the cholesterol burden in HoFH? Methods We measured hsCRP and IL-6 in stored plasma from 52 genetically confirmed HoFH patients collected at first presentation. Age, gender, body mass index, lipid profiles, cardiovascular history and lipid-lowering therapy (LLT) were obtained from patient files. Distributions were summarised as mean (SD) or median (IQR). Associations were determined by Spearman correlation, and groups were compared by Mann-Whitney tests. Results The median age of participants was 17 years and 51.9% (n=27) were female. The mean LDL-C was 560.7 (±140) mg/dL. Median Lp(a)was 78 (IQR 37-112) nmol/L with 30.8% (n=16) of patients having an Lp(a) > 105 nmol/L. Half of all participants had commenced LLT at the time of sample collection and 16 were on high intensity statins. Despite the young age, the prevalence of ASCVD was 17.3% (n=9). No participants had hypertension or diabetes although 9 were overweight and 4 were obese. Ten (19.2%) were current or former smokers. The median hsCRP for the cohort was 1.0 (0.4 - 3.5) mg/L with only 30.8% having an hsCRP > 3 mg/L. The median IL-6 was 2.0 (1.3 - 3.5) pg/mL. There was no difference in hsCRP and IL-6 between those on or off LLT. In the HoFH patients with established ASCVD, hsCRP was numerically higher (3.1 vs 1.0 mg/L; p=0.07) however, this group was older and heavier. hsCRP correlated with IL-6 (ρ=0.61; p < 0.001) but was not associated with LDL-C (ρ=0.11; p=0.46) - see figure , non-HDL-C (ρ=0.10; p=0.49), remnant cholesterol (ρ=0.05; p=0.73) or Lp(a) (ρ=0.02; p=0.92). Findings remained unchanged after log transformation and adjustment for age and BMI. Mean hsCRP, but not IL-6, was higher in adults than children (1.35 vs 0.65 mg/L; p=0.03) and correlated with BMI (ρ = 0.31; p =0.02). Conclusion The lipid burden of HoFH is not associated with biomarkers of systemic inflammation. Elevated hsCRP within the cohort is attributed to age and adiposity, rather than LDL-C and is not a marker of ASCVD.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.